JP7096639B2 - テロメラーゼ由来のペプチドを含む樹状細胞治療剤及び免疫治療剤、及びこれを用いる治療方法 - Google Patents
テロメラーゼ由来のペプチドを含む樹状細胞治療剤及び免疫治療剤、及びこれを用いる治療方法 Download PDFInfo
- Publication number
- JP7096639B2 JP7096639B2 JP2016247814A JP2016247814A JP7096639B2 JP 7096639 B2 JP7096639 B2 JP 7096639B2 JP 2016247814 A JP2016247814 A JP 2016247814A JP 2016247814 A JP2016247814 A JP 2016247814A JP 7096639 B2 JP7096639 B2 JP 7096639B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cancer
- peptide
- composition
- dendritic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016247814A JP7096639B2 (ja) | 2016-12-21 | 2016-12-21 | テロメラーゼ由来のペプチドを含む樹状細胞治療剤及び免疫治療剤、及びこれを用いる治療方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016247814A JP7096639B2 (ja) | 2016-12-21 | 2016-12-21 | テロメラーゼ由来のペプチドを含む樹状細胞治療剤及び免疫治療剤、及びこれを用いる治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018100243A JP2018100243A (ja) | 2018-06-28 |
| JP2018100243A5 JP2018100243A5 (enExample) | 2020-01-30 |
| JP7096639B2 true JP7096639B2 (ja) | 2022-07-06 |
Family
ID=62714976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016247814A Active JP7096639B2 (ja) | 2016-12-21 | 2016-12-21 | テロメラーゼ由来のペプチドを含む樹状細胞治療剤及び免疫治療剤、及びこれを用いる治療方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7096639B2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111518216B (zh) * | 2019-02-02 | 2024-02-02 | 上海细胞治疗集团有限公司 | 多肽、含有多肽的组合物及其在肿瘤免疫中的应用 |
| CN112402596B (zh) * | 2019-08-22 | 2023-12-08 | 上海细胞治疗集团有限公司 | 多肽组合物及疫苗 |
| JP6782503B1 (ja) * | 2019-12-12 | 2020-11-11 | 康基 土方 | 癌治療用細胞組成物を製造する方法、それにより製造される癌治療用細胞組成物、及び癌治療用細胞組成物を用いた癌の治療方法 |
| KR102514849B1 (ko) * | 2021-10-28 | 2023-03-28 | 전남대학교산학협력단 | 수지상 세포를 표적하는 신규한 펩타이드, 및 이를 포함하는 암 치료용 조성물 |
| JP2023119754A (ja) * | 2022-02-17 | 2023-08-29 | Ｄｃ－Ｂｉｏｔｅｃｈ株式会社 | カクテル樹状細胞ワクチンの製造方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014030375A (ja) | 2012-08-02 | 2014-02-20 | Hiroyuki Abe | 単球またはｎｋ細胞を入手する方法 |
-
2016
- 2016-12-21 JP JP2016247814A patent/JP7096639B2/ja active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014030375A (ja) | 2012-08-02 | 2014-02-20 | Hiroyuki Abe | 単球またはｎｋ細胞を入手する方法 |
Non-Patent Citations (4)
| Title |
|---|
| Biotherapy，2008年，Vol.22, No.5，pp.327-331 |
| Experimental Hematology，2007年，Vol.35，pp.297-304 |
| NATURE MEDICINE，2000年，Vol.6, No.8，pp.1011-1017 |
| 日本内科学会雑誌，2013年，Vol.102, No.7，pp.1751-1758 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018100243A (ja) | 2018-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20170128557A1 (en) | Dendritic Cell Therapeutic Agent and Immunotherapeutic Agent Comprising Peptide Derived from Telomerase, and Therapeutic Methods Using the Same | |
| CN103088103B (zh) | 活化辅助t细胞的方法以及用于该方法的组合物 | |
| EP1966369B1 (en) | Method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer | |
| US8129183B2 (en) | Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours | |
| RU2451521C2 (ru) | Sparc-производные антигенные пептиды отторжения опухоли и лекарственные средства, содержащие их | |
| EP2787005A1 (en) | Targeted cancer immune therapy | |
| JP2018100243A (ja) | テロメラーゼ由来のペプチドを含む樹状細胞治療剤及び免疫治療剤、及びこれを用いる治療方法 | |
| WO2007071409A1 (en) | Method for treating colon cancer | |
| US20230256066A1 (en) | Pharmaceutical composition for use in the treatment of cancer | |
| JP5087925B2 (ja) | 新規癌抗原ペプチド及びその用途 | |
| CN112980787A (zh) | 一种特异性杀伤肿瘤细胞的免疫细胞制剂及其制备方法和应用 | |
| CN101072582B (zh) | 作为癌症疫苗佐剂的α胸腺肽 | |
| JP4780540B2 (ja) | サバイビン由来癌抗原ペプチド | |
| RU2593003C2 (ru) | Препарат экзосом - онкосом и способ иммунотерапии солидных опухолей с его использованием | |
| EA028081B1 (ru) | Композиция для лечения рака простаты, способ лечения индивидуума с раком простаты и способ индукции иммунотерапевтического ответа у данного индивидуума | |
| CN102898508B (zh) | 封闭TGF-β受体或IL-10受体的多肽、其药物组合物及其用途 | |
| NZ569105A (en) | A method for the expansion of tumor-reactive CD4 positive T-helper and CD positive T-lymphocytes | |
| CN112972491B (zh) | 癌症治疗或预防用细胞组合物、及其制造方法 | |
| WO2007018198A1 (ja) | Hla-a2陽性者用hsp105由来癌拒絶抗原ペプチド及びこれを含む医薬 | |
| CN119055758B (zh) | 一种树突状细胞治疗性疫苗制剂及其制备方法和应用 | |
| CN107188959B (zh) | 抗原肽t790m-6及其在制备治疗非小细胞肺癌的药物中的应用 | |
| CN107188958B (zh) | 抗原肽t790m-5及其在制备治疗非小细胞肺癌的药物中的应用 | |
| CN115246870A (zh) | 活化的树突细胞及其在治疗癌症中的应用 | |
| CN102191271A (zh) | 抗肿瘤重组质粒、基因疫苗及其制备方法和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191212 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191212 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201215 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210312 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210527 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20211012 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220210 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220210 |
|
| C11 | Written invitation by the commissioner to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C11 Effective date: 20220301 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20220407 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20220412 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220510 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220518 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220531 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220624 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7096639 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |